MEMBRANE-ALTERATIONS AS CAUSES OF IMPAIRED SIGNAL-TRANSDUCTION IN ALZHEIMERS-DISEASE AND AGING

被引:152
作者
ROTH, GS
JOSEPH, JA
MASON, RP
机构
[1] TUFTS UNIV, USDA ARS, CTR HUMAN NUTR, BOSTON, MA 02111 USA
[2] ALLEGHENY SINGER RES INST, NEUROSCI RES CTR, PITTSBURGH, PA 15212 USA
关键词
D O I
10.1016/0166-2236(95)93902-A
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Changes in cell-membrane composition in normal aging and in Alzheimer's and other age-related diseases appear to result in impaired neurotransmitter-triggered signal transduction. The impaired signal transduction seems to be related to dysfunctions in the coupling of G proteins to their receptors and effecters. Direct demonstration of altered physiochemical properties of brain tissue of patients with Alzheimer's disease has been achieved by small-angle X-ray diffraction. In this disease, thinner membranes correlate with a 30% decrease in moles of cholesterol: phospholipid. Such changes can affect directly the coupling and uncoupling properties of G proteins, and can account for signal transduction deficits. These findings offer a complementary alternative to the beta-amyloid hypothesis, and an opportunity to consider new types of therapeutic interventions.
引用
收藏
页码:203 / 206
页数:4
相关论文
共 57 条
[1]  
ANSON RM, 1992, BRAIN RES, V598, P302
[2]   ALTERED BETA-ADRENERGIC-RECEPTOR FUNCTION IN SUBJECTS WITH SYMPTOMATIC MITRAL-VALVE PROLAPSE [J].
ANWAR, A ;
KOHN, SR ;
DUNN, JF ;
HYMER, TK ;
KENNEDY, GT ;
CRAWFORD, MH ;
OROURKE, RA ;
KATZ, MS .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1991, 302 (02) :89-97
[3]   DIFFERENTIAL ALTERATION OF VARIOUS CHOLINERGIC MARKERS IN CORTICAL AND SUBCORTICAL REGIONS OF HUMAN-BRAIN IN ALZHEIMERS-DISEASE [J].
ARAUJO, DM ;
LAPCHAK, PA ;
ROBITAILLE, Y ;
GAUTHIER, S ;
QUIRION, R .
JOURNAL OF NEUROCHEMISTRY, 1988, 50 (06) :1914-1923
[4]   AGE-RELATED-CHANGES IN CARDIAC MUSCARINIC RECEPTORS - DECREASED ABILITY OF THE RECEPTOR TO FORM A HIGH-AFFINITY AGONIST BINDING STATE [J].
BAKER, SP ;
MARCHAND, S ;
ONEIL, E ;
NELSON, CA ;
POSNER, P .
JOURNALS OF GERONTOLOGY, 1985, 40 (02) :141-146
[5]   DRUGS TO TREAT AGE-RELATED NEURODEGENERATIVE PROBLEMS - THE FINAL FRONTIER OF MEDICAL SCIENCE [J].
BARTUS, RT .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1990, 38 (06) :680-695
[6]   LEVELS OF PHOSPHOLIPID CATABOLIC INTERMEDIATES, GLYCEROPHOSPHOCHOLINE AND GLYCEROPHOSPHOETHANOLAMINE, ARE ELEVATED IN BRAINS OF ALZHEIMERS-DISEASE BUT NOT OF DOWNS-SYNDROME PATIENTS [J].
BLUSZTAJN, JK ;
GONZALEZCOVIELLA, IL ;
LOGUE, M ;
GROWDON, JH ;
WURTMAN, RJ .
BRAIN RESEARCH, 1990, 536 (1-2) :240-244
[7]   TETRAHYDROAMINOACRIDINE AND ALZHEIMERS-DISEASE [J].
BYRNE, EJ ;
ARIE, T .
BRITISH MEDICAL JOURNAL, 1994, 308 (6933) :868-869
[8]   CATECHOLAMINE-STIMULATED GTPASE ACTIVITY IN TURKEY ERYTHROCYTE-MEMBRANES [J].
CASSEL, D ;
SELINGER, Z .
BIOCHIMICA ET BIOPHYSICA ACTA, 1976, 452 (02) :538-551
[9]  
CHAKRAVARTI A, 1989, AM J HUM GENET, V44, P799
[10]   AREA-SPECIFIC ALTERATIONS IN MUSCARINIC STIMULATED LOW K-M GTPASE ACTIVITY IN AGING AND ALZHEIMERS-DISEASE - IMPLICATIONS FOR ALTERED SIGNAL-TRANSDUCTION [J].
CUTLER, R ;
JOSEPH, JA ;
YAMAGAMI, K ;
VILLALOBOSMOLINA, R ;
ROTH, GS .
BRAIN RESEARCH, 1994, 664 (1-2) :54-60